Literature DB >> 15958773

Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment.

R Thonhofer, M Gaugg, M Kriessmayr, H J Neumann, L Erlacher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15958773      PMCID： PMC1755549          DOI： 10.1136/ard.2004.026252

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  12 in total

1.  A practical approach to screening psoriasis patients for therapy with biologic agents.

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

2.  A practical approach to monitoring patients on biological agents for the treatment of psoriasis.

Authors:  Jason J Emer; Amylynne Frankel; Joshua A Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

Review 3.  Is there truly a risk of lymphoma from biologic therapies?

Authors:  Erica Dommasch; Joel M Gelfand
Journal:  Dermatol Ther       Date:  2009 Sep-Oct       Impact factor: 2.851

4.  Safe use of infliximab for the treatment of severe perianal Crohn's disease after diagnosis and treatment of lymphoma.

Authors:  Carlos Bernardes; Pedro Russo; Diana Carvalho; Joana Saiote; Jaime Ramos
Journal:  Clin J Gastroenterol       Date:  2017-11-22

5.  Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.

Authors:  Hélène Théophile; Thierry Schaeverbeke; Ghada Miremont-Salamé; Abdelilah Abouelfath; Valentine Kahn; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

6.  Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry.

Authors:  X Mariette; F Tubach; H Bagheri; M Bardet; J M Berthelot; P Gaudin; D Heresbach; A Martin; T Schaeverbeke; D Salmon; M Lemann; O Hermine; M Raphael; P Ravaud
Journal:  Ann Rheum Dis       Date:  2009-10-14       Impact factor: 19.103

7.  Spontaneous regression of EBV-associated diffuse lymphoproliferative disease in a patient with rheumatoid arthritis after discontinuation of etanercept treatment.

Authors:  Sung-Hoon Park; Chae-Gi Kim; Ji-Young Kim; Jung-Yoon Choe
Journal:  Rheumatol Int       Date:  2007-10-18       Impact factor: 2.631

Review 8.  Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature.

Authors:  Rita Rizzi; Paola Curci; Mario Delia; Erminia Rinaldi; Antonia Chiefa; Giorgina Specchia; Vincenzo Liso
Journal:  Med Oncol       Date:  2008-05-07       Impact factor: 3.064

9.  Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies.

Authors:  Corinne Miceli-Richard; Nicolas Gestermann; Corinne Amiel; Jérémie Sellam; Marc Ittah; Stephan Pavy; Alejandra Urrutia; Isabelle Girauld; Guislaine Carcelain; Alain Venet; Xavier Mariette
Journal:  Arthritis Res Ther       Date:  2009-05-26       Impact factor: 5.156

10.  Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

Authors:  Matthew L Stoll; Alisa C Gotte
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.